[1] |
黄飞, 赵雁林. 加快结核病监测系统信息化建设. 中国防痨杂志, 2020, 42(7):649-652. doi: 10.3969/j.issn.1000-6621.2020.07.001.
doi: 10.3969/j.issn.1000-6621.2020.07.001
|
[2] |
李涛, 杜昕, 陈伟, 等. 中国结核病管理信息监测与监控的回顾与展望. 中国防痨杂志, 2020, 42(7):657-661. doi: 10.3969/j.issn.1000-6621.2020.07.003.
doi: 10.3969/j.issn.1000-6621.2020.07.003
|
[3] |
Zhao Y, Xu S, Wang L, et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012, 366(23):2161-2170. doi: 10.1056/NEJMoa1108789.
doi: 10.1056/NEJMoa1108789
URL
|
[4] |
郑惠文, 赵雁林. 中国结核病耐药监测现状与监测体系建设. 中国实用内科杂志, 2015, 35(8):647-650. doi: 10.7504/nk2015070102.
doi: 10.7504/nk2015070102
|
[5] |
马爱静, 赵雁林. 耐药结核病的流行和监测现状. 中国抗生素杂志, 2018, 43(5):502-506. doi: 10.3969/j.issn.1001-8689.2018.05.002.
doi: 10.3969/j.issn.1001-8689.2018.05.002
|
[6] |
Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis, 2015, 61(2):219-227. doi: 10.1093/cid/civ255.
doi: 10.1093/cid/civ255
URL
|
[7] |
Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retros-pective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis, 2017, 17(3):275-284. doi: 10.1016/S1473-3099(16)30418-2.
doi: 10.1016/S1473-3099(16)30418-2
URL
|
[8] |
Jiang Q, Liu Q, Ji L, et al. Citywide transmission of multidrug-resistant tuberculosis under China’s rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis, 2020, 71(1):142-151. doi: 10.1093/cid/ciz790.
doi: 10.1093/cid/ciz790
pmid: 31504306
|
[9] |
Shea J, Halse TA, Lapierre P, et al. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases ofMycobacterium tuberculosis in New York State. J Clin Microbiol, 2017, 55(6):1871-1882. doi: 10.1128/JCM.00298-17.
doi: 10.1128/JCM.00298-17
URL
|
[10] |
Coll F, McNerney R, Preston MD, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med, 2015, 7(1):51. doi: 10.1186/s13073-015-0164-0.
doi: 10.1186/s13073-015-0164-0
URL
|
[11] |
Pankhurst LJ, Del Ojo Elias C, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med, 2016, 4(1):49-58. doi: 10.1016/S2213-2600(15)00466-X.
doi: S2213-2600(15)00466-X
pmid: 26669893
|
[12] |
Walker TM, Kohl TA, Omar SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis, 2015, 15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6.
doi: 10.1016/S1473-3099(15)00062-6
URL
|
[13] |
Takiff HE, Feo O. Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. Lancet Infect Dis, 2015, 15(9):1077-1090. doi: 10.1016/S1473-3099(15)00071-7.
doi: 10.1016/S1473-3099(15)00071-7
URL
|
[14] |
Nikolayevskyy V, Niemann S, Anthony R, et al. Role and value of whole genome sequencing in studying tuberculosis transmission. Clin Microbiol Infec, 2019, 25(11):1377-1382. doi: 10.1016/j.cmi.2019.03.022.
doi: 10.1016/j.cmi.2019.03.022
|
[15] |
Satta G, Lipman M, Smith GP, et al. Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? Clin Microbiol Infect, 2018, 24(6):604-609. doi: 10.1016/j.cmi.2017.10.030.
doi: 10.1016/j.cmi.2017.10.030
URL
|
[16] |
Talarico S, Silk B, Shaw T, et al. Whole-genome sequencing for investigation of recent TB transmission in the United States: current uses and future plans[R/OL].[2021-05-18].https://www.cdc.gov/tb/programs/genotyping/Tuberculosis_WGS_Training_Module.pdf.
|
[17] |
European Centre for Disease Prevention and Control. Expert opinion on whole genome sequencing for public health surveillance. Stockholm: European Centre for Disease Prevention and Control, 2016.
|
[18] |
National TB Strategy team. Collaborative TB strategy for england, 2015 to 2020-end of programme report. London: Public Health England, 2020.
|
[19] |
Tagliani E, Cirillo DM, Ködmön C, et al. EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU. Lancet Infect Dis, 2018, 18(4):377. doi: 10.1016/S1473-3099(18)30132-4.
doi: S1473-3099(18)30132-4
pmid: 29582760
|
[20] |
Tagliani E, Anthony R, Kohl TA, et al. Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017—2019: an ECDC pilot study. Eur Respir J, 2021, 57(1):2002272. doi: 10.1183/13993003.02272-2020.
doi: 10.1183/13993003.02272-2020
|
[21] |
Kwong JC, McCallum N, Sintchenko V, et al. Whole genome sequencing in clinical and public health microbiology. Pathology, 2015, 47(3):199-210. doi: 10.1097/PAT.0000000000000235.
doi: 10.1097/PAT.0000000000000235
pmid: 25730631
|
[22] |
Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol, 2019, 17(9):533-545. doi: 10.1038/s41579-019-0214-5.
doi: 10.1038/s41579-019-0214-5
|
[23] |
Walter KS, Colijn C, Cohen T, et al. Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences. Microb Genom, 2020, 6(8): mgen000418. doi: 10.1099/mgen.0.000418.
doi: 10.1099/mgen.0.000418
|
[24] |
CRyPTIC Consortium and the 100, 000 Genomes Project, Allix-Béguec C, Arandjelovic I, et al. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N Engl J Med, 2018, 379(15):1403-1415. doi: 10.1056/NEJMoa1800474.
doi: 10.1056/NEJMoa1800474
URL
|